A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Clinical trial NCT06383507 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06383507
Sponsor: Zhejiang University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Tumor Advanced Solid Tumor Renal Cell Carcinoma Ovarian Cancer Cervix Cancer Head and Neck Squamous Cell Carcinoma Nasopharyngeal Carcinoma

Start date: 2024-04-22
Primary completion: 2027-04-21
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.